In line with this, Wortmannin treatment prevented GRK2 induced Akt and GSK3β phosphorylation, suggesting an essential role for GRK2-PI3Kγ interaction in GRK2 mediated cardiac hypertrophy (Fig 7D–7F). The gene discussed is GSK3B; the disease is cardiac hypertrophy.